Trials / Completed
CompletedNCT02291822
Retrospective Study of MRI in Pediatric Patients
The Safety and Efficacy of MULTIHANCE at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients Who Are Less Than 2 Years of Age
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Bracco Diagnostics, Inc · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Collection of already existing data and images for patients \< 2 years of age having MultiHance administration for a MRI of the brain or spine. MR Images will be reviewed during a prospectively designed blinded reading of the images.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gadobenate Dimeglumine | gadolinium contrast agent |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-11-17
- Last updated
- 2016-07-19
Source: ClinicalTrials.gov record NCT02291822. Inclusion in this directory is not an endorsement.